These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 28842145)

  • 21. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
    Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
    Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of a multidimensional post-discharge disease management program for heart failure patients-economic evaluation along a one-year observation period.
    Egelseer-Bruendl T; Jahn B; Arvandi M; Puntscher S; Santamaria J; Brunelli L; Weissenegger K; Pfeifer B; Neururer S; Rissbacher C; Huber A; Fetz B; Kleinheinz C; Modre-Osprian R; Kreiner K; Siebert U; Poelzl G
    Clin Res Cardiol; 2024 Aug; 113(8):1232-1241. PubMed ID: 38353683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).
    Sanders-van Wijk S; van Asselt AD; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Vuillomenet A; Peter M; Pfisterer ME; Brunner-La Rocca HP;
    JACC Heart Fail; 2013 Feb; 1(1):64-71. PubMed ID: 24621800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.
    Thijssen J; van den Akker van Marle ME; Borleffs CJ; van Rees JB; de Bie MK; van der Velde ET; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):25-34. PubMed ID: 23998638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent Treatment.
    Ha D; Kerr J; Ries AL; Fuster MM; Lippman SM; Murphy JD
    Am J Phys Med Rehabil; 2020 Mar; 99(3):233-240. PubMed ID: 31361623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of alternative treatments for depression in low-income women.
    Beil H; Beeber LS; Schwartz TA; Lewis G
    J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.
    McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER
    J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
    Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
    Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis.
    Naci H; de Lissovoy G; Hollenbeak C; Custer B; Hofmann A; McClellan W; Gitlin M
    J Med Econ; 2012; 15(2):293-304. PubMed ID: 22115328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental cost-effectiveness of guideline-directed medical therapies for heart failure.
    Banka G; Heidenreich PA; Fonarow GC
    J Am Coll Cardiol; 2013 Apr; 61(13):1440-6. PubMed ID: 23433562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C.
    Cammà C; Petta S; Cabibbo G; Ruggeri M; Enea M; Bruno R; Capursi V; Gasbarrini A; Alberti A; Craxì A;
    J Hepatol; 2013 Oct; 59(4):658-66. PubMed ID: 23707373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
    Sanon M; Taylor DC; Parthan A; Coombs J; Paolantonio M; Sasane M
    J Med Econ; 2013; 16(1):150-9. PubMed ID: 22762291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of age on cost-effectiveness of unicompartmental knee arthroplasty compared with total knee arthroplasty in the U.S.
    Ghomrawi HM; Eggman AA; Pearle AD
    J Bone Joint Surg Am; 2015 Mar; 97(5):396-402. PubMed ID: 25740030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cost-effectiveness analysis of the effect of pregabalin versus usual care in the treatment of refractory neuropathic pain in routine medical practice in Spain.
    de Salas-Cansado M; Pérez C; Saldaña MT; Navarro A; Rejas J
    Pain Med; 2012 May; 13(5):699-710. PubMed ID: 22594706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of cardiac resynchronization therapy: perspective from Argentina.
    Poggio R; Augustovsky F; Caporale J; Irazola V; Miriuka S
    Int J Technol Assess Health Care; 2012 Oct; 28(4):429-35. PubMed ID: 23006489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of onabotulinumtoxinA for the treatment of wrist and hand disability due to upper-limb post-stroke spasticity in Scotland.
    Doan QV; Gillard P; Brashear A; Halperin M; Hayward E; Varon S; Lu ZJ
    Eur J Neurol; 2013 May; 20(5):773-80. PubMed ID: 23278954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care - a multi-state survival model based on a randomized controlled trial.
    Gao L; Scuffham P; Ball J; Stewart S; Byrnes J
    J Med Econ; 2021; 24(1):87-95. PubMed ID: 33406944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
    Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
    Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.